Chlamydia Trachomatis anticorps

N° du produit ABIN2859518

L’anticorps anti-Chlamydia Trachomatis Monoclonal Souris est utilisé pour la détection de Chlamydia Trachomatis dans des échantillons de Chlamydia trachomatis. Il a été validé pour IF, EIA et IHC (p).

Aperçu rapide pour Chlamydia Trachomatis anticorps (ABIN2859518)

Antigène: Chlamydia Trachomatis

Reactivité: Chlamydia trachomatis

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Chlamydia Trachomatis est non-conjugé

Application: Immunofluorescence (IF), Enzyme Immunoassay (EIA), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: BDI168

Détail du produit anti-Chlamydia Trachomatis anticorps

Purification: Protein A chromatography

Pureté: > 90 % pure

Immunogène: C. trachomatis LGV 2 elementary bodies

Isotype: IgG1

Information d'application

Indications d'application: ELISA. IFA. Immunohistochemistry on frozen sections.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Concentration: 0,1mg/mL (OD280nm, E0.1% = 1.4)

Buffer: 0.01 M PBS, pH 7.2 containing 0.09 % Sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store the antibody at -20 °C. Avoid repeated freezing and thawing.
Shelf life: one year from despatch.

Date de péremption: 12 months

Détails sur Chlamydia Trachomatis

Antigène: Chlamydia Trachomatis

Classe de substances: Bacteria

Sujet: Chlamydia trachomatis is an intracellular organism. Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men. Chlamydial infections are believed to be one of the most common of all STDs. It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year. Thus, there are many undiagnosed cases of chlamydia in the community. It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5 % to 10 %. Chlamydia is one of the leading causes of blindness in underdeveloped countries.